The WACC of BiVictriX Therapeutics PLC (BVX.L) is 12.6%.
Range | Selected | |
Cost of equity | 11.40% - 14.40% | 12.90% |
Tax rate | 15.30% - 15.60% | 15.45% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 11.2% - 14.1% | 12.6% |
Category | Low | High |
Long-term bond rate | 4.0% | 4.5% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | 1.24 | 1.35 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 11.40% | 14.40% |
Tax rate | 15.30% | 15.60% |
Debt/Equity ratio | 0.03 | 0.03 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 11.2% | 14.1% |
Selected WACC | 12.6% | |